China-based healthcare investment firm Sunland Fund has raised an undisclosed amount for its latest fund, from limited partners including pharmaceutical companies Lepu Medical and Shandong Buchang Pharma, DealStreetAsia reported yesterday.
Sunland targets medical and healthcare technology developers and its portfolio companies include medical imaging technology provider Deepwise as well as medical supplies provider GKHT Medical Technology, which raised more than $154m in a September 2019 series C round.
The fund’s other LPs include Rebud Capital, China Everbright, China Development Bank Capital, CICC Genesis Fund and China’s Ministry of Finance, in addition to other state-backed investors, according to a statement cited by DealStreetAsia.
